-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-kidney-disease-anemia-2011_executive.pdf
January 01, 2011 - clinical
outcomes
• Patient outcomes of interest are:
– Mortality
– Morbidity (e.g., cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-participant-generated-registries-guide-3rd-ed-addendum-white-paper.pdf
February 01, 2018 - specific information about general health and physiological measures of
skin, eye, gastrointestinal, cardiac
-
effectivehealthcare.ahrq.gov/products/osteoarthritis-knee-update/research-protocol
June 16, 2016 - ameliorate the complications posed by obesity when it coexists with pathological conditions such as cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/patient-participant-generated-registries-guide-3rd-ed-addendum-white-paper.pdf
February 01, 2018 - specific information about general health and physiological measures of
skin, eye, gastrointestinal, cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritization-selection-of-harms.pdf
February 01, 2018 - agent therapy (statin
+ lipid modifying
medication) and
intensification of statin
therapy
Cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-37-opiod-use-adults-comments.pdf
November 03, 2020 - obstructive sleep apnea,xviii chronic
obstructive pulmonary disease (COPD), chronic
kidney disease,xix cardiac … function;
o obstructive sleep apnea
o ASA score
o chronic obstructive
pulmonary disease (COPD)
o cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper-2015.pdf
January 01, 2015 - Preoperative statin
therapy for patients undergoing cardiac
surgery.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-update_executive.pdf
August 01, 2016 - uncontrolled hypertension, preservation
or salvage of kidney function, prevention
or treatment of cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdf
March 01, 2013 - Cabergoline therapy
and the risk of cardiac valve regurgitation in patients with
hyperprolactinemia
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rti-item-bank-bias-precision_research.pdf
September 01, 2011 - Evaluation of Technologies for Identifying
Acute Cardiac Ischemia in Emergency
Departments. … Cardiac Resynchronization Therapy for
Congestive Heart Failure.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_disposition-comments.pdf
January 01, 2015 - described as submaximal.Page
111 Table 25 states that the number of patients
experiencing sudden cardiac … therefore leads one to conclude that no patients in the
groups listed in Table 25 died of sudden cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/study-design-framework_research.pdf
March 01, 2012 - disease, one would
have to define a composite outcome of death or myocardial infarction or other cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1412.pdf
October 01, 2015 - donor lung supply, new
alternatives such as the use of lungs from older donors, lungs donated after cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/meditation_executive.pdf
January 01, 2014 - seeing
null results may be the type of populations studied; for
example, three TM trials enrolled cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-knee-update_research-protocol.pdf
June 15, 2016 - ameliorate the complications posed by
obesity when it coexists with pathological
conditions such as cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
January 01, 2006 - in phone
interview and 23%
reported using cc aspirin
Acute MI
requiring
admission or
sudden cardiac … : 0.86
(0.70, 1.04)
No dose-relationship;
increased risk for males
and for individuals with a
cardiac
-
effectivehealthcare.ahrq.gov/products/patient-safety-databases-prescriptions/research
August 26, 2008 - drugs (commonly known as COX-2 inhibitors, and used for pain management) are documented to increase cardiac … the recent discoveries that cyclooxygenase-2 inhibitor nonsteroidal anti-inflammatory drugs increase cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
January 01, 2016 - ranges from $20,000 to
$35,000.54 The cost generally includes preoperative lab work, x-ray fees, cardiac … benefits would be realized only if these
therapies do not pose risk of serious adverse events (i.e., cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-illness-priorities_research.pdf
September 01, 2011 - they are people with other aspects to their lives and are not
wholly characterized with labels as cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-chronic-conditions-interventions_disposition-comments.pdf
August 13, 2012 - JAMA 2003) testing
the effectiveness of enhanced depression care on cardiac
outcomes which includes